Friday, August 28, 2020 7:46:13 AM
Press Release | 08/25/2020
Ljubljana, Slovenia, Aug. 25, 2020 (GLOBE NEWSWIRE) -- Rafarma Pharmaceuticals, Inc. “OTC:(RAFA)” is pleased to announce that it has established a new corporate entity in Thailand. The entity is registered under the name of RAFARMA (THAILAND) CO., LTD. The Company intends to use the business entity for entering into new association agreements with Thai universities. New association agreements are currently under negotiations and are expected to cover research and joint projects in production of cannabis based products. Also, in the light of recent agreement with R. & D. BIOCOGENCY LABORATORIES GROUP, the Company will use the new entity to conduct clinical trials and license its new products in Thailand for future distribution in South-East Asian markets.
For more information, contact:
RAFARMA
(307) 429-2029
FEATURED Cannabix Technologies Launches New Compact Breath Logix Workplace Series and Prepares for Delivery to South Africa • May 7, 2024 8:51 AM
Moon Equity Holdings, Corp. Announces Acquisition of Wikolo, Inc. • MONI • May 7, 2024 9:48 AM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM